Analyst Downgrades: Abbott Labs, Workday, and Avago

Analysts downwardly revised their ratings on Abbott Laboratories (NYSE:ABT), Workday Inc (NYSE:WDAY), and Avago Technologies Ltd (NASDAQ:AVGO)

Aug 27, 2015 at 9:27 AM
facebook twitter linkedin


Analysts are weighing in on pharmaceutical firm Abbott Laboratories (NYSE:ABT), financial management firm Workday Inc (NYSE:WDAY), and semiconductor concern Avago Technologies Ltd (NASDAQ:AVGO). Here's a quick roundup of today's bearish brokerage notes on ABT, WDAY, and AVGO.

  • ABT is making noise this morning, denying rumors that it's in pursuit of St. Jude Medical, Inc. (NYSE:STJ). What's more, Abbott Laboratories Inc is pointed 3.8% higher ahead of the bell, despite a price-target cut to $51 from $55 at Goldman Sachs. Most analysts are in ABT's corner, with 11 of 17 offering up "buy" or better endorsements. Until the past week's broad-market bloodshed, ABT was in the black year-to-date, and flirting with all-time highs north of $50, but ended yesterday at $43.98.
  • WDAY is bracing for a 2.8% slump, as the analyst crowd reacts to a lackluster current-quarter billings outlook. Roughly a dozen brokerage firms slashed their price targets on Workday Inc, with UBS slicing its target by $31 to $85. Short sellers will likely be pleased, though, as short interest accounts for 9.1% of WDAY's total float, representing almost 12 sessions' worth of pent-up buying demand, at the stock's average daily trading volume. On Wednesday, WDAY ended at $72.40, down 11.3% in 2015.

Get the skinny on all the biggest stories of the morning… Sign up now to get Schaeffer's Midday Market Check delivered straight to your inbox!

Celebrate 40 Years of Schaeffer's With 4 FREE Stock Picks!


 




 
Special Offers from Schaeffer's Trading Partners